CyberChemics: The 'irrational' alternative

Compared with rational drug design, the use of artificial intelligence to discover drugs is "irrational," said CyberChemics Chairman David Noever. AI for drug discovery is based on a process that mimics natural selection.

CyberChemics believes that AI can be used to identify compounds with desired traits because it is capable of extremely high throughput even when starting with very little information. In the race to discover drugs active against the protein targets that are rapidly being unearthed, CyberChemics "can keep up with genomics," Noever said...